Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
about
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceHuman Papilloma Viruses and Breast Cancer.Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.Prevalence of HPV infection and other risk factors in a Fijian population.The potential impact of HPV-16 reactivation on prevalence in older Australians.Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact.The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental modelsType-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational studyPre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New ZealandHuman Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia.Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.The impact of smoking on HPV infection and the development of anogenital warts.Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.Social determinants in the sexual health of adolescent Aboriginal Australians: a systematic review.Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trialHuman papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer.Completing the cervical screening pathway: Factors that facilitate the increase of self-collection uptake among under-screened and never-screened women, an Australian pilot study.The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality
P2860
Q26745696-CB361779-D21B-420D-9850-903B49C4FF59Q27308147-2F365DD4-7203-4B8D-831D-AB88ABA6C7D2Q30764433-7F57D207-9887-498F-B486-3B9F7C0531B3Q33694151-1587E1C9-89D0-4855-B452-87CA106BB379Q33769284-3E6E31F1-9FA3-4796-9A8E-9C250AE6230EQ34435211-9668E8DE-B7C3-4ED3-9B93-1AAFFB8CC18AQ34493286-1DB912AC-D7AB-4858-ACB5-58DBF90A5E99Q34583160-A9FCF6AD-7B7C-44AA-B028-832443BBA699Q34604698-4E5C87DC-C7D5-44CD-8339-BA6EF59AD200Q34777452-6C6E2644-FCEE-4395-A8B7-A66179EDA4A4Q34987731-C7843DE5-4F8F-4B13-9B23-C8683436C910Q35752872-2AF46031-708E-44C8-ACFC-5E8A927BDD12Q35985481-EB1D589D-4DE6-4E87-85DF-BDBDD71A04F2Q36019886-59AD7B07-DBF0-45D5-8A39-87A707CEB06FQ36441874-8BCDC2C3-4875-4E70-8B03-26BDE58DD6E3Q37983132-19B931F3-448C-4BE0-BB87-BF4E4E729351Q38220753-05391EC9-C657-4DB7-8632-9803AEF1E455Q38373388-5915CB5E-254D-4E95-A327-6356C5981ADAQ38820160-F3F62893-0788-40C7-B3DF-5010828CD1F8Q39122442-27D0036F-221B-44A4-971E-F248FF612279Q41677108-473D393D-038A-4EF0-A333-8994E5C9B848Q45355812-1DDA5E3C-28AD-4E87-AEB2-61096A926C14Q55234176-F34C60E7-6BBE-449C-8ED7-517FB043038BQ58749274-551100DD-E8F3-43F6-A94D-FBE63ADF83FF
P2860
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human papillomavirus prevalenc ...... tional HPV vaccination program
@ast
Human papillomavirus prevalenc ...... tional HPV vaccination program
@en
Human papillomavirus prevalenc ...... tional HPV vaccination program
@nl
type
label
Human papillomavirus prevalenc ...... tional HPV vaccination program
@ast
Human papillomavirus prevalenc ...... tional HPV vaccination program
@en
Human papillomavirus prevalenc ...... tional HPV vaccination program
@nl
prefLabel
Human papillomavirus prevalenc ...... tional HPV vaccination program
@ast
Human papillomavirus prevalenc ...... tional HPV vaccination program
@en
Human papillomavirus prevalenc ...... tional HPV vaccination program
@nl
P2093
P2860
P356
P1433
P1476
Human papillomavirus prevalenc ...... tional HPV vaccination program
@en
P2093
David W Smith
John R Condon
Matthew P Stevens
Peter B McIntyre
Suzanne M Garland
WHINURS study group
P2860
P2888
P356
10.1186/1741-7015-9-104
P407
P577
2011-09-13T00:00:00Z
P5875
P6179
1037297254